Kazia Therapeutics Ltd. (KZIA)
7.81
-0.26
(-3.22%)
USD |
NASDAQ |
Oct 23, 16:00
7.81
0.00 (0.00%)
After-Hours: 20:00
Kazia Therapeutics Max Drawdown (5Y) : 99.58% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.58% |
| August 31, 2026 | 99.58% |
| July 31, 2026 | 99.58% |
| June 30, 2026 | 99.58% |
| May 31, 2026 | 99.58% |
| April 30, 2026 | 99.58% |
| March 31, 2026 | 99.58% |
| February 28, 2026 | 99.58% |
| January 31, 2026 | 99.58% |
| December 31, 2025 | 99.58% |
| November 30, 2025 | 99.58% |
| October 31, 2025 | 99.58% |
| September 30, 2025 | 99.58% |
| August 31, 2025 | 99.58% |
| July 31, 2025 | 99.58% |
| June 30, 2025 | 99.58% |
| May 31, 2025 | 99.58% |
| April 30, 2025 | 99.58% |
| March 31, 2025 | 99.48% |
| February 28, 2025 | 99.44% |
| January 31, 2025 | 99.07% |
| December 31, 2024 | 98.80% |
| November 30, 2024 | 98.69% |
| October 31, 2024 | 98.69% |
| September 30, 2024 | 98.69% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.69% |
| July 31, 2024 | 98.69% |
| June 30, 2024 | 98.65% |
| May 31, 2024 | 98.63% |
| April 30, 2024 | 98.63% |
| March 31, 2024 | 98.63% |
| February 29, 2024 | 98.27% |
| January 31, 2024 | 97.98% |
| December 31, 2023 | 97.38% |
| November 30, 2023 | 97.28% |
| October 31, 2023 | 97.15% |
| September 30, 2023 | 96.59% |
| August 31, 2023 | 96.59% |
| July 31, 2023 | 96.59% |
| June 30, 2023 | 96.59% |
| May 31, 2023 | 96.59% |
| April 30, 2023 | 96.59% |
| March 31, 2023 | 96.59% |
| February 28, 2023 | 96.59% |
| January 31, 2023 | 96.59% |
| December 31, 2022 | 96.59% |
| November 30, 2022 | 96.02% |
| October 31, 2022 | 94.38% |
| September 30, 2022 | 94.03% |
| August 31, 2022 | 94.03% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Alterity Therapeutics Ltd. | 96.94% |
| Algorae Pharmaceuticals Ltd. | 98.33% |
| Clinuvel Pharmaceuticals Ltd. | 81.49% |
| Immuron Ltd. | 92.60% |
| Amplia Therapeutics Ltd. | 99.29% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -82.14 |
| Beta (5Y) | 2.259 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.4% |
| Historical Sharpe Ratio (5Y) | -0.4601 |
| Historical Sortino (5Y) | -1.131 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 48.26% |